CELG

Celgene Corporation News Headlines

$95.13
*  
0.51
0.53%
Get CELG Alerts
*Delayed - data as of Sep. 30, 2014 15:38 ET  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Nasdaq 100 Movers: MYL, EBAY
9/30/2014 12:44:31 PM - BNK Invest

Agios to Present Data on AG-120 in November, Shares Rises - Analyst Blog
9/29/2014 5:30:00 PM - Zacks.com

Celgene Has A Very Bright Future Ahead
9/29/2014 4:26:00 PM - Seeking Alpha

Stocks Fight Off Predictable Weakness, But Expect More Downside
9/29/2014 4:05:00 AM - Seeking Alpha

Celgene: Jim Cramer's Favorite Biotech Juggernaut
9/26/2014 12:22:00 PM - Seeking Alpha

Jim Cramer's Stop Trading: Does Agios Pharmaceuticals Have a Monumental Cancer Treatment?
9/26/2014 11:58:00 AM - TheStreet

Cramer: Taking solace in biotech
9/26/2014 9:02:56 AM - optionMONSTER

The Best Biotech Stock for Your Growth Portfolio
9/25/2014 8:45:02 AM - Motley Fool

Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market
9/24/2014 8:24:00 PM - TheStreet

Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
9/24/2014 5:30:00 PM - Zacks.com

Jim Cramer's Mad Dash: Celgene and Morgan Stanley Still Have Upside
9/24/2014 10:58:00 AM - TheStreet

Celgene: FDA Okays Oral Otezla To Treat Patients With Plaque Psoriasis
9/23/2014 3:27:00 PM - RTT News

VOO, HD, CELG, HPQ: Large Outflows Detected at ETF
9/22/2014 11:20:49 AM - BNK Invest

Restoring My Growth Portfolio With Restoration Hardware By Closing Out Celgene
9/21/2014 5:00:00 PM - Seeking Alpha

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
9/19/2014 5:40:00 PM - Zacks.com

Celgene Int''l. Appoints Tuomo Pätsi As President, EMEA Region - Quick Facts
9/19/2014 8:39:00 AM - RTT News

Celgene Int'l. Appoints Tuomo Pätsi As President, EMEA Region - Quick Facts
9/19/2014 8:39:00 AM - RTT News

3 Best Stocks for Investing in Biotech
9/18/2014 8:35:02 AM - Motley Fool

Rosetta Blooms, FLXN Knocked Down, RNA In Demand, Concert Strikes Sweet Note
9/17/2014 11:58:00 PM - RTT News

Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog
9/17/2014 3:00:00 PM - Zacks.com

3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 10:52:17 AM - InvestorPlace Media

Safety Worries Over Celgene's Experimental Crohn's Drug Overblown
9/17/2014 8:26:00 AM - TheStreet

Concert Pharma Begins Phase 1 Trial Of CTP-730 - Quick Facts
9/17/2014 7:19:00 AM - RTT News

Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14)
9/17/2014 5:29:00 AM - Seeking Alpha

The Cheapest And Most Expensive S&P 500 Stocks Utilizing CAPE And PEG Ratios
9/16/2014 5:00:00 PM - Seeking Alpha